Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric) Clinical Trials

A listing of Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (34) clinical trials

The purpose of this study is to demonstrate the efficacy, safety and tolerability of SPN-810 in the treatment of impulsive aggression in subjects with Attention Deficit/Hyperactivity Disorder (ADHD) in conjunction with standard ADHD treatment. Approximately 291 subjects aged 6 to 12 years with ADHD and comorbid impulsive aggression will be ...

Phase N/A

Evaluate pediatric patients with ADHD

Phase N/A

The purpose of this study is to evaluate the effect of SPN-810 for the treatment of impulsive aggression (IA) in adolescents diagnosed with ADHD when taken in conjunction with standard ADHD treatment.  

Phase

Clinical Trials of Texas, Inc. is conducting an investigational study for Aggression in Teenagers with ADHD. Signs of aggression include but are not limited to: fighting, throwing tantrums, and getting in trouble at school. Teens must currently be on ADHD medications.  

Phase N/A

The purpose of this study is to evaluate the effect of 4-week SPN-810 treatment on brain functioning in patients aged 8-12 years with ADHD and associated feature of IA. This will be achieved using functional magnetic resonance imaging (fMRI) in conjunction with the point subtraction aggression paradigm (PSAP) Task, a ...

Phase

Children between the ages of 6-12 years who are diagnosed with impulsive aggression comorbid with ADHD and have participated in the 810P301 or 810P302 study are invited to participate in this study. This is a Phase 3 open label extension (OLE) study with the objective of collecting long-term safety data ...

Phase

This study will evaluate the efficacy and safety of high doses of SPN-812 ER in adolescents (12-17 years old).

Phase

This clinical study is researching the safety and effectiveness of a new medication for pediatric patients who are diagnosed with ADHD and have symptoms of impulsive aggression. 

Phase

The purpose of this study is to demonstrate the efficacy, safety and tolerability of SPN-810 in the treatment of impulsive aggression in subjects with Attention Deficit/Hyperactivity Disorder (ADHD) in conjunction with standard ADHD treatment. Approximately 291 subjects aged 6 to 12 years with ADHD and comorbid impulsive aggression will be ...

Phase N/A